VERVE THERAPEUTICS INC (VERV) Stock Analyst Ratings
NASDAQ:VERV - Nasdaq - US92539P1012 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to VERV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.33. This target is 218.32% above the current price.
VERV was analyzed by 15 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about VERV.
In the previous month the buy percentage consensus was at a similar level.
VERV was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-12 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-09 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | Stifel | Maintains | Buy -> Buy |
| 2024-02-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-09-13 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-08-29 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2023-08-15 | Guggenheim | Maintains | Buy -> Buy |
| 2023-08-11 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-06-16 | Canaccord Genuity | Reiterate | Buy -> Buy |
| 2023-05-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-04-13 | Canaccord Genuity | Initiate | Buy |
| 2023-02-01 | Cantor Fitzgerald | Initiate | Neutral |
| 2022-12-15 | Goldman Sachs | Initiate | Sell |
| 2022-11-08 | RBC Capital | Maintains | Outperform |
| 2022-10-06 | Credit Suisse | Initiate | Neutral |
| 2022-08-25 | Stifel | Upgrade | Hold -> Buy |
| 2022-07-18 | BMO Capital | Maintains | Outperform |
| 2022-06-17 | BMO Capital | Initiate | Outperform |
| 2022-02-18 | RBC Capital | Initiate | Outperform |
| 2021-09-24 | Stifel | Initiate | Hold |
| 2021-07-12 | Guggenheim | Initiate | Buy |
| 2021-07-12 | William Blair | Initiate | Outperform |
| 2021-07-12 | JP Morgan | Initiate | Neutral |
| 2021-07-12 | Jefferies | Initiate | Buy |